吉林大学学报(医学版)

• 基础研究 • 上一篇    下一篇

不同剂量普奈洛尔治疗婴儿血管瘤的疗效评价

钟淑霞1,陶育纯2,周俊峰1,姚 蕾1,李珊山1   

  1. 1.吉林大学第一医院皮肤科,吉林 长春 130021;2.吉林大学公共卫生学院流行病与卫生统计学教研室,吉林 长春 130021
  • 收稿日期:2014-04-02 出版日期:2014-07-28 发布日期:2015-01-18
  • 通讯作者: 李珊山(Tel:0431-88782615,E-mail:shansalee@163.com) E-mail:shansalee@163.com
  • 作者简介:钟淑霞(1966-),女,吉林省榆树市人,主治医师,医学硕士,主要从事医学激光治疗皮肤病的临床研究。
  • 基金资助:

    吉林省科技厅科技发展计划项目资助课题(3D513U003428)

Evaluation on efficacy of  different doses of propranolol in treatment of infantile hemangioma

ZHONG Shu-xia1,TAO Yu-chun2,ZHOU Jun-feng1,YAO Lei1,LI Shan-shan1   

  1. 1.Department of Dermatology,First Hospital,Jilin University,Changchun 130021,China;2.Department of Epidemiology and Health Statistics,School of  Public Health,Jilin University,Changchun 130021,China
  • Received:2014-04-02 Online:2014-07-28 Published:2015-01-18

摘要:

目的:探讨不同剂量普奈洛尔治疗婴儿混合型和深层血管瘤的临床效果,为血管瘤的治疗提供理论和实验依据。方法:将入选的62例混合型和深层血管瘤患儿随机分为普奈洛尔低剂量组和高剂量组,每组31例,分别采用1.5和3.0 mg.kg-1?d-1普奈洛尔口服,每日3次,疗程6个月,动态观察血管瘤的体积变化及不良事件发生率。结果:根据Achauer 疗效判定标准进行疗效比较,普奈洛尔低剂量组患儿总有效率为80.65%(其中Ⅰ级 6例,Ⅱ级 9例,Ⅲ级 11例,Ⅳ级5例),普奈洛尔高剂量组患儿总有效率为93.55%(其中Ⅰ级 2例,Ⅱ级4例,Ⅲ级 10例,Ⅳ级15例),普奈洛尔高剂量组疗效优于低剂量组(P<0.01)。不同部位和不同类型血管瘤疗效比较差异均无统计学意义(P>0.05)。2组患儿不良事件发生率比较差异无统计学意义(P>0.05)。 结论:普奈洛尔3.0 mg?kg-1?d-1口服治疗婴儿混合型和深层血管瘤疗效明显增加,但不良反应未见增加。建议临床治疗婴儿血管瘤时,可提高普奈洛尔的剂量,以提高治疗效果。

关键词:  , 血管瘤;普奈洛尔;疗效;不良反应

Abstract:

Objective To investigate the clinical effects of different doses of propranolol in treatment of infantile mixed and deep hemangioma,and to provid theoretical and experimental evidence for  the treatment of hemangioma.Methods The selected 62 patients with  mixed and deep hemangioma were divided randomly into  low dose(1.5mg?kg-1?d-1)  and high dose(3.0 mg?kg-1?d-1) of propranolol groups,3 times a day,6 months as a course,the changes in hemangioma size and the incidence of adverse reactions  were recorded.Results The efficacy  was evaluated using Achauer system.The total effective rate was 80.65% in low dose of propranolol group and 93.55% in high dose of propranolol group,including  6 cases of class Ⅰ(poor),9 cases of class Ⅱ(moderate),11 cases of classⅢ(good),and 5 cases of class Ⅳ(excellent)in low dose propranolol group;while  2 cases of class Ⅰ(poor),4 cases of class Ⅱ(moderate),10 cases of   class Ⅲ(good) and 15 cases of Ⅳ(excellent)in high dose of propranolol group.The efficacy in  high dose of proprandol group  was significantly better than that in  low dose of proprandol group(P<0.05),there were no significant differences in the efficacies between different sites and different types(P>0.05) and there was no significant difference in the  incidence of  adverse reaction between  two groups (P>0.05).Conclusion The efficacy of oral 3.0 mg?kg-1?d-1 propranolol in treatment of infantile mixed and deep hemangioma  is  increased significantly,and there is no significant adverse reactions after increasing doses.Therefore,high dose of propranolol should  be recommended in order to improve the therapeutic effect.

Key words: hemangioma, propranolol, therapeutic effect, adverse reaction

中图分类号: 

  •